These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4818902)

  • 21. [Clinical aspects of immunoaggressive cirrhosis of the liver in children].
    Malakhovskiĭ IuE; Belova LI; Likhachev AA; Ledak NA
    Vopr Okhr Materin Det; 1972 Oct; 17(10):12-7. PubMed ID: 4656401
    [No Abstract]   [Full Text] [Related]  

  • 22. [Australia-SH antigen isolation in patients with liver disease].
    Kaboth U; Schober A; Arndt HJ; Vido I; Creutzfeldt W
    Bibl Haematol; 1971; 37():245-50. PubMed ID: 5138911
    [No Abstract]   [Full Text] [Related]  

  • 23. [Possible use of immunofluorescence in chronic agressive hepatitis].
    Storch W; Emmrich R
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(3):119-23. PubMed ID: 4599279
    [No Abstract]   [Full Text] [Related]  

  • 24. Interrelations of hepatitis B antigen and autoantibodies in chronic idiopathic liver disease.
    Finlayson ND; Krohn K; Anderson KE; Jokelainen PT; Prince AM
    Gastroenterology; 1972 Oct; 63(4):646-52. PubMed ID: 4562020
    [No Abstract]   [Full Text] [Related]  

  • 25. [Australia antigen and chronic hepatic diseases in the western African].
    Payet M; Saimot G; Menache D; Chemaly P; Coulaud JP; Schlegel N
    Ann Med Interne (Paris); 1972 Feb; 123(2):175-9. PubMed ID: 4341131
    [No Abstract]   [Full Text] [Related]  

  • 26. [Quantitative alterations of the immunoglobuline classes and the presence of autoantibodies in liver diseases (author's transl)].
    Ossena A; Gola F; Raho L; Taroni G
    Quad Sclavo Diagn; 1978 Sep; 15(3):316. PubMed ID: 379904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnosis of the immunopathologic reactions in liver diseases].
    Meyer KH
    Med Klin; 1976 Sep; 71(36):1401-12. PubMed ID: 785186
    [No Abstract]   [Full Text] [Related]  

  • 28. [HLA antigens in chronic active liver diseases].
    Loginov AS; Krel' PE; Fedrunova VS; Pevnitskiĭ LA
    Ter Arkh; 1981; 53(6):110-3. PubMed ID: 7281021
    [No Abstract]   [Full Text] [Related]  

  • 29. [Australia antigen in various liver diseases (except acute hepatitis). 3].
    Migneco G; Mansueto S; Tripi S
    G Mal Infett Parassit; 1971 Dec; 23(12):1125-6. PubMed ID: 5151318
    [No Abstract]   [Full Text] [Related]  

  • 30. [Presence of Australia antigen, histocompatibility (HL-A) antigens, and autolymphocytotoxins (CoCoCy) during different forms of hepatitis and cirrhosis].
    Bertrams J; Kuwert E; Reis HE; Selmair H; Wiese W
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):372-7. PubMed ID: 4154614
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hepatitis-associated antigen in hospitalized patients].
    Skinhoj P
    Ugeskr Laeger; 1971 Sep; 133(37):1830-2. PubMed ID: 5122526
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance of high titers of various autoantibodies in the diagnosis and monitoring of chronic liver diseases].
    Ninova-Bradistilova D; Naumov N; Krustev Z; Ognianov M; Maleev A
    Vutr Boles; 1983; 22(6):46-52. PubMed ID: 6608830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Autoantibodies and viral markers of hepatitis in 163 patients with acute and chronic hepatic diseases].
    Sepúlveda C; Meléndez M; Velasco M
    Rev Med Chil; 1984 Jul; 112(7):681-4. PubMed ID: 6096952
    [No Abstract]   [Full Text] [Related]  

  • 34. [Occurrence of so-called Australia antigen in virus hepatitis patients in the population from the vicinity of Bialystok].
    Boron P; Sokolewicz E
    Dtsch Gesundheitsw; 1970 Dec; 25(51):2408-11. PubMed ID: 5501406
    [No Abstract]   [Full Text] [Related]  

  • 35. Alpha(1)-fetoprotein in chronic liver disease.
    Silver HK; Gold P; Shuster J; Javitt NB; Freedman SO; Finlayson ND
    N Engl J Med; 1974 Sep; 291(10):506-8. PubMed ID: 4137189
    [No Abstract]   [Full Text] [Related]  

  • 36. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoimmunity in liver diseases.
    Doniach D
    Prog Clin Immunol; 1972; 1():45-70. PubMed ID: 4142094
    [No Abstract]   [Full Text] [Related]  

  • 38. Australia antigen and circulating antibodies in chronic aggressive hepatitis.
    Findor J; Igartua EB; Alonso A; Domecq R; Bozzola C
    Acta Hepatogastroenterol (Stuttg); 1973; 20(2):98-102. PubMed ID: 4201582
    [No Abstract]   [Full Text] [Related]  

  • 39. Significance of serum complement levels in chronic liver disease.
    Finlayson ND; Krohn K; Fauconnet MH; Anderson KE
    Gastroenterology; 1972 Oct; 63(4):653-9. PubMed ID: 4116547
    [No Abstract]   [Full Text] [Related]  

  • 40. [Detection of the Australia antigen and of the corresponding antibody in pathology and in hospital personnel].
    Ménaché D; Boyer C; Schlegel N
    Arch Fr Mal App Dig; 1971 Dec; 60(12):649-64. PubMed ID: 5158155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.